Bafisontamab
Modify Date: 2024-04-05 19:48:00
Bafisontamab structure
|
Common Name | Bafisontamab | ||
|---|---|---|---|---|
| CAS Number | 2437210-79-0 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BafisontamabBafisontamab (EMB-01) is a bispecific antibody targeting EGFR and cMET with antitumor activity[1]. |
| Name | Bafisontamab |
|---|
| Description | Bafisontamab (EMB-01) is a bispecific antibody targeting EGFR and cMET with antitumor activity[1]. |
|---|---|
| Related Catalog | |
| Target |
EGFR c-Met |
| In Vivo | Bafisontamab (EMB-01) 在 PDX 和 CDX 肿瘤模型中诱导的抗肿瘤活性明显强于抗 EGFR 单抗或抗 cMet 单抗。Bafisontamab 在抗 EGFR mAb 耐药肿瘤模型中表现出显著的抗肿瘤活性[1]。 |
| References |
| No Any Chemical & Physical Properties |